BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 23606009)

  • 1. Binding of sulfamethazine to β-cyclodextrin and methyl-β-cyclodextrin.
    Zoppi A; Delrivo A; Aiassa V; Longhi MR
    AAPS PharmSciTech; 2013 Jun; 14(2):727-35. PubMed ID: 23606009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulfamethoxazole:hydroxypropyl-β-cyclodextrin complex: preparation and characterization.
    Garnero C; Aiassa V; Longhi M
    J Pharm Biomed Anal; 2012 Apr; 63():74-9. PubMed ID: 22361661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solubility and release modulation effect of sulfamerazine ternary complexes with cyclodextrins and meglumine.
    Aloisio C; de Oliveira AG; Longhi M
    J Pharm Biomed Anal; 2014 Nov; 100():64-73. PubMed ID: 25129645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of aripiprazole solubility by complexation with (2-hydroxy)propyl-β-cyclodextrin using spray drying technique.
    Mihajlovic T; Kachrimanis K; Graovac A; Djuric Z; Ibric S
    AAPS PharmSciTech; 2012 Jun; 13(2):623-31. PubMed ID: 22535520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified beta-cyclodextrin.
    Figueiras A; Carvalho RA; Ribeiro L; Torres-Labandeira JJ; Veiga FJ
    Eur J Pharm Biopharm; 2007 Sep; 67(2):531-9. PubMed ID: 17451924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and solid-state characterization of inclusion complexes formed between miconazole and methyl-beta-cyclodextrin.
    Ribeiro A; Figueiras A; Santos D; Veiga F
    AAPS PharmSciTech; 2008; 9(4):1102-9. PubMed ID: 18975116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physicochemical, in silico and in vivo evaluation of a danazol-beta-cyclodextrin complex.
    Jadhav GS; Vavia PR
    Int J Pharm; 2008 Mar; 352(1-2):5-16. PubMed ID: 18023545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and solid-state characterization of bupivacaine hydrochloride cyclodextrin complexes aimed for buccal delivery.
    Jug M; Maestrelli F; Bragagni M; Mura P
    J Pharm Biomed Anal; 2010 May; 52(1):9-18. PubMed ID: 20004541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physicochemical characterization of efavirenz-cyclodextrin inclusion complexes.
    Sathigari S; Chadha G; Lee YH; Wright N; Parsons DL; Rangari VK; Fasina O; Babu RJ
    AAPS PharmSciTech; 2009; 10(1):81-7. PubMed ID: 19148759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of triclosan inclusion complexes with β-cyclodextrin and its water-soluble polymeric derivative.
    Jug M; Kosalec I; Maestrelli F; Mura P
    J Pharm Biomed Anal; 2011 Apr; 54(5):1030-9. PubMed ID: 21215544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dihydroartemisinin-cyclodextrin complexation: solubility and stability.
    Ansari MT; Iqbal I; Sunderland VB
    Arch Pharm Res; 2009 Jan; 32(1):155-65. PubMed ID: 19183889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved Aqueous Solubility and Antihypercholesterolemic Activity of Ezetimibe on Formulating with Hydroxypropyl-β-Cyclodextrin and Hydrophilic Auxiliary Substances.
    Srivalli KM; Mishra B
    AAPS PharmSciTech; 2016 Apr; 17(2):272-83. PubMed ID: 26077622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preformulation study of the inclusion complex irbesartan-beta-cyclodextrin.
    Hirlekar R; Kadam V
    AAPS PharmSciTech; 2009; 10(1):276-81. PubMed ID: 19283492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quercetin/beta-cyclodextrin solid complexes prepared in aqueous solution followed by spray-drying or by physical mixture.
    Borghetti GS; Lula IS; Sinisterra RD; Bassani VL
    AAPS PharmSciTech; 2009; 10(1):235-42. PubMed ID: 19280349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of β-cyclodextrin on the Properties of Norfloxacin Form A.
    Chierentin L; Garnero C; Chattah AK; Delvadia P; Karnes T; Longhi MR; Salgado HR
    AAPS PharmSciTech; 2015 Jun; 16(3):683-91. PubMed ID: 25511811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation and physicochemical characterization of clarithromycin-citric acid-cyclodextrins ternary complexes.
    Zhang X; Zhang Y; Zhong D; Chen Y; Li S
    Drug Dev Ind Pharm; 2007 Feb; 33(2):163-71. PubMed ID: 17454048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and comparison of binary and ternary inclusion complexes of aripiprazole using L-arginine/lysine and MβCD/HPβCD by using different molar ratios.
    Awais S; Afridi M; Batool A; Ansari MT; Sultana K; Momal H; Alsanie WF; S Alamri A; Alhomrani M
    Pak J Pharm Sci; 2024 Jan; 37(1(Special)):245-255. PubMed ID: 38747276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on trimethoprim:hydroxypropyl-β-cyclodextrin: aggregate and complex formation.
    Garnero C; Zoppi A; Genovese D; Longhi M
    Carbohydr Res; 2010 Nov; 345(17):2550-6. PubMed ID: 20933225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Water-soluble Complex of Curcumin with Cyclodextrins: Enhanced Physical Properties For Ocular Drug Delivery.
    Maria DN; Mishra SR; Wang L; Abd-Elgawad AH; Soliman OA; El-Dahan MS; Jablonski MM
    Curr Drug Deliv; 2017 Sep; 14(6):875-886. PubMed ID: 27501714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ATR/Raman and fractal characterization of HPBCD/progesterone complex solid particles.
    Fini A; Ospitali F; Zoppetti G; Puppini N
    Pharm Res; 2008 Sep; 25(9):2030-40. PubMed ID: 18597163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.